OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $130,734 Invested

2012

Rush University Medical Center

Elliott Mufson, PhD

CSF proNGF: a putative biomarker for Alzheimer's disease

  • Funding Amount: $130,734
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed